Publication not explained
Read the Original
This page is a summary of: Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary Hyperparathyroidism, International Journal of Toxicology, March 2016, SAGE Publications, DOI: 10.1177/1091581816633407.
You can read the full text:
Be the first to contribute to this page